See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Research Area · Pain

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
11093 4-Quinolone-3-Carboxamide Derivative New 1314230-69-7 ≥98% 2012-01-30 128.388330263966 4-quinolone-3-carboxamide-derivative CB1 CB2 cannabinoid CBs central peripheral receptors inverse agonists antinociception AM630 analgesic pain osteoporosis synthetic ligands mice analgesic AM 630 AM-630 128.388330263966
9000310 8-methyl Nonanoic Acid 5963-14-4 ≥98% 2008-10-10 6.261127071822 8-methyl-nonanoic-acid Isocapric Acid capsaicin intermediate bacteria growth substrate antimicrobial capsicum bacterial bacterium 6.261127071822
10012588 A-803467 944261-79-4 ≥98% 2009-02-14 0.216574585635 a-803467 Nav1.8 sodium channels neuropathic pain inflammatory blockers inhibitors inhibits inhibition TTX-resistance TTX-R 0.216574585635
10010118 AM1241 444912-48-5 >97% 2007-08-29 104.824301021262 am1241 CB1 CB2 cannabinoids receptors agonists antagonists antinociception AM630 AM251 AM-1241 AM 1241 cannabinoids cbs synthetic 104.824301021262
10707 AM2201 Exclusive 335161-24-5 ≥98% 2011-03-07 122.875871207581 am2201 cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM-2201 AM 2201 122.875871207581
10706 AM2201-d5 Exclusive - ≥99% deuterated product 2011-05-16 41.327683482825 am2201-d5 cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM2201 AM-2201 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry standards 41.327683482825
9001029 AM2201 N-(4-fluoropentyl) isomer Exclusive - ≥98% 2011-08-11 65.690699556963 am2201-n-4-fluoropentyl-isomer forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 central peripheral 65.690699556963
10006974 AM630 164178-33-0 ≥98% 2009-02-09 47.163132289748 am630 Iodopravadoline neurochemistry neuroscience cannabinoids CB1 CB2 antagonist inverse agonist antinociception pain receptors 47.163132289748
10567 AM694 Exclusive 335161-03-0 ≥95% 2011-01-31 55.781724575096 am694 cannabinoids CB1 CB2 receptors pain JWH neuroscience AM-694 AM 694 55.781724575096
13823 AX 048 Exclusive 873079-69-7 ≥98% 2010-09-15 9.193425414365 ax-048 Inflammation antihyperalgesia cPLA2 phospholipases inhibitors inhibition inhibits AX048 AX-048 signaling signalling group IVA PLA2 cannabinoids cbs synthetic Acids Octanoic Octanoic Acids 9.193425414365
10010088 CAY10526 Exclusive 938069-71-7 >98% 2007-09-07 352.918618784530 cay10526 mPGES-1 mPGES1 microsomal prostaglandin E2 PGE2 synthase prostanoid modulators inflammatory inflammation pain inhibition inhibitors inhibits expressions 352.918618784530
10012565 CAY10568 22913-17-3 ≥98% 2008-05-28 4.645377532228 cay10568 Santinamide TRPV1 QX314 cationic lidocaine capsaicin pain ion channel anesthetics analgesia nociception CAY10568 4.645377532228
10010032 CAY10570 Exclusive 875014-22-5 >98% 2008-06-03 16.145870165746 cay10570 FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases cannabinoids 16.145870165746
13164 CAY10589 Exclusive 1077626-52-8 ≥98% 2009-06-23 1.657500000000 cay10589 Microsomal prostaglandin E2 synthase-1 mPGES-1 inhibitors cyclooxygenase cyclooxygenase-2 COX-2 PGE2 5-lipoxygenase 5-LO COX-1 leukotrienes LTB4 LTC4 LTD4 LTE4 dual inhibits inhibition inflammation fever pain signaling sagnalling 1.657500000000
10820 CAY10651 Exclusive - ≥98% 2011-06-15 0.911602209945 cay10651 Glutamate neurotransmitters receptors mGlu5 pain anxiety antagonists gastresophageal reflux diseases dyskinesia fragile X syndromes drug addictions cortical astrocytes functional binding assays mobilization calcium CNS 0.911602209945
10010398 CB-13 432047-72-8 ≥98% 2009-06-30 30.332404939876 cb-13 CRA-13 cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 30.332404939876
13289 CB-86 Exclusive 1150586-64-3 ≥98% 2010-05-03 17.649021310181 cb-86 cannabinoids receptors CB1 CB2 antinociception agonists resorcinol anandamides hybrids CB86 CB 86 partial agonist neural antagonist antinociceptive effects 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione 6-Azauridine 6 Azauridine Azauridine cannabinoids cbs synthetic 17.649021310181
10917 (−)-CP 47, 497 114753-51-4 ≥98% 2011-05-05 14.108511156878 -cp-47-497 cannabinoids analgesia CB1 hypothermia motor deppressant anticonvulsant Δ9-THC analogs activity hypothermic effects cannabinoids cbs synthetic 13218 14.108511156878
10910 (+)-CP 47,497 134308-14-8 ≥98% 2011-05-05 13.627848173453 -cp-47-497 cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids 13.627848173453
10913 (±)-CP 47,497 70434-82-1 ≥98% 2011-05-05 29.260334883041 -cp-47-497 receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 16851 29.260334883041
10908 (±)-CP 47,497-C8-homolog Exclusive 70434-92-3 ≥98% 2011-05-06 33.211843073581 -cp-47-497-c8-homolog CAY10596; Cannabicyclohexanol cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic 33.211843073581
10686 (±)-CP 47,497-C8-homolog-d7 (solution) Exclusive - ≥99% deuterated forms (d1-d7) 2011-03-14 21.771818898971 -cp-47-497-c8-homolog-d7-solution Cannabicyclohexanol-d7 cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS GC LC standards stds 10914 21.771818898971
13216 (±)-CP 47,497-C8-homolog (solution) Exclusive 70434-92-3 ≥98% 2009-04-23 43.502412536909 -cp-47-497-c8-homolog-solution CAY10596; Cannabicyclohexanol cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic 10908 43.502412536909
10687 (±)-CP 47,497-d11 (solution) Exclusive - ≥99% deuterated forms (d1-d11) 2011-02-16 23.337757971923 -cp-47-497-d11-solution receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 10907 23.337757971923
13218 (−)-CP 47,497 (solution) 114753-51-4 ≥98% 2009-04-13 16.635470743702 -cp-47-497-solution cannabinoids analgesia CB1 hypothermia motor deppressant anticonvulsant Δ9-THC analogs activity hypothermic effects cannabinoids cbs synthetic 10917 16.635470743702
13219 (+)-CP 47,497 (solution) 134308-14-8 ≥98% 2009-04-13 17.680171898900 -cp-47-497-solution cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids 10910 17.680171898900
16851 (±)-CP 47,497 (solution) 70434-82-1 ≥98% 2008-12-10 40.643750448281 -cp-47-497-solution receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 10913 40.643750448281
13608 (+)-CP 55,940 Exclusive - ≥98% 2010-05-20 16.533217169570 -cp-55-940 Δ9-THC cannabinoids CB1 CB2 pain analgesic cannabinoids cbs synthetic 16.533217169570
13241 (±)-CP 55,940 Exclusive 83003-12-7 ≥98% 2009-05-20 24.597446286065 -cp-55-940 cannabinoids analgetic pain THC thermal mechanical chemicals receptors CB1 cannabimimetic potent non-selective CP55940 CP-55940 cbs synthetic 24.597446286065
9000639 Docosahexaenoyl Serotonin Exclusive 283601-58-1 ≥98% 2010-05-18 5.120520915548 docosahexaenoyl-serotonin N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA L-alpha-Glycerylphosphorylcholine L alpha Glycerylphosphorylcholine Glycerophospholipids Choline Choline Glycerophospholipids Phosphoglycerides Choline 3-Phosphocholine Glycerol Glycerylphosphorylcholine Glycerophosphate Choline Glycerol 3-Phosphocholine Glycerol 3 Phosphocholine Choline Phosphoglycerides Glycerophosphorylcholine Choline Glycerophosphate Alphoscerate Choline Phosphatidylcholines Choline Alphoscerate Alfoscerate Choline Phosphatidylcholine Choline Alfoscerate 5.120520915548
9000640 Eicosapentaenoyl Serotonin Exclusive 199875-71-3 ≥98% 2010-09-10 1.131144435675 eicosapentaenoyl-serotonin N-arachidonoyl serotonins AA-5-HT AA5HT AA 5 HT AA-5HT AA5HT antagonists fatty acids Amide hydrolase FAAH transient receptors potential vanilloid type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA Triacylglycerols Triacylglycerol Triglycerides 1.131144435675
10477 EP2 Receptor Polyclonal PE Antibody - 2010-07-07 24.681933701657 ep2-receptor-polyclonal-pe-antibody Prostaglandin E2 Receptor 2; PGE2 Receptor 2 R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons 24.681933701657
10010183 Fatty Acid Amide Hydrolase (human recombinant) - Whole-cell lysate 2008-11-05 29.586385161799 fatty-acid-amide-hydrolase-human-recombinant FAAH (human recombinant) FAAHs endocannabinoid AEA cannabinoids 2-AG 2AG proteins FAAH-1 acids amides hydrolases 29.586385161799
10010182 Fatty Acid Amide Hydrolase Western Ready Control - 66 kDa (His-tagged), 63 kDa (native) 2007-07-06 5.770911602210 fatty-acid-amide-hydrolase-western-ready-control Oleamide Hydrolase; FAAH; Anandamide Aminohydrolase fatty acid amides sleep nociception cancers liver brain testes uterus small intestine ocular tissues western blots blotting WB inhibitors 5.770911602210
10011347 Glycerophospho-N-Arachidonoyl Ethanolamine Exclusive 201738-25-2 ≥97% 2009-03-13 14.693112338857 glycerophospho-n-arachidonoyl-ethanolamine Glycerophospho-Arachidonoyl Ethanolamide; Glycerophosphoanandamide; GP-NArE anandamides arachidonoyl ethanolamide AEA NAE GDE1 cannabinoids neurotransmitters CB1 CB2 glycerophosphodiesterase 1 NAPE N-Acyl Phosphatidylethanolamide cbs synthetic 14.693112338857
10224 GPR55 Polyclonal Antibody - 2010-01-19 38.641258879242 gpr55-polyclonal-antibody G Protein-Coupled Receptor 55 proteins receptors antibodies western blots WB ICC signals signaling nucleotides THC amino acids blotting immunoblotting immunocytochemistry signalling cannabinoids cbs synthetic 38.641258879242
10010372 GW 842166X 666260-75-9 ≥98% 2008-05-23 35.737209944751 gw-842166x inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic 35.737209944751
10010410 GW 848687X 612831-24-0 ≥98% 2009-11-25 15.437038674033 gw-848687x Receptors EP1 PGE2 vasoconstriction bronchoconstriction hyperalgesia allodynia gastric protection relief hyperthermia sleep antagonists thromboxanes TP inflammation arthritis pain inflammatory GW848687X GW-848687X 15.437038674033
10011038 Hemopressin - 2009-08-13 32.880710339384 hemopressin peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive cannabinoids cbs synthetic 32.880710339384
11513 HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New - 2012-01-16 131.388888888888 hmgb1-monoclonal-antibody-clone-img19n15f4 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 131.388888888888
10215 IDFP 615250-02-7 ≥98% 2009-03-09 15.622209944751 idfp Isopropyl Dodecylfluorophosphonate CB1 agonist nerve agent serins organophophorus MAGL inhibitors inhibits inhibition FAAH 2-AG 2AG AEA arachidonic acids MGL inhibitors cannabinoids 15.622209944751
10266 JWH 007 Exclusive 155471-10-6 ≥98% 2011-02-23 39.806735761424 jwh-007 agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy JWHs CBs JWH-007 JWH007 JWH-7 JWH 7 JWH7 39.806735761424
10486 JWH 007-d9 - ≥99% deuterated product 2010-10-11 42.265883416430 jwh-007-d9 agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy deuterateds deuteriums mass spectrometry MS standards JWHs JWH007-d9 JWH-007-d9 cannabinoids cbs synthetic JWH7-d9 JWH 7-d9 JWH-7-d9 42.265883416430
10900 JWH 018 209414-07-3 ≥98% 2011-05-05 39.860919038187 jwh-018 cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 13169 39.860919038187
9000844 JWH 018 2-hydroxyindole metabolite Exclusive - ≥98% 2010-10-26 31.132379618776 jwh-018-2-hydroxyindole-metabolite cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated cbs synthetic JWH-018 JWH018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 31.132379618776
10711 JWH 018 2-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-02-25 24.113084443524 jwh-018-2-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 24.113084443524
9000851 JWH 018 4-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 46.814097970685 jwh-018-4-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics JWH-018 JWH018 209414-07-3 JWH018-metabolite JWH 018-metabolite one CBs M-1 M1 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 46.814097970685
10712 JWH 018 4-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-02-25 33.195926243109 jwh-018-4-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 33.195926243109
9000852 JWH 018 5-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 69.338314927368 jwh-018-5-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBS M-2 M2 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 69.338314927368
10713 JWH 018 5-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-03-11 27.502696454894 jwh-018-5-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards M-2 M2 JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 27.502696454894
9000853 JWH 018 6-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 42.598628357426 jwh-018-6-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 42.598628357426
10714 JWH 018 6-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-03-25 47.737945073679 jwh-018-6-hydroxyindole-metabolite-d9 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 47.737945073679
10697 JWH 018 6-methoxyindole analog Exclusive - ≥98% 2011-02-15 30.978954958867 jwh-018-6-methoxyindole-analog analogs metabolites cannabinoids receptors agonists CBs JWH-018 JWH018 JWH18 JWH-18 JWH 18 30.978954958867
9000854 JWH 018 7-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 37.179710050102 jwh-018-7-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite four 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 37.179710050102
10715 JWH 018 7-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-07-26 29.253143271526 jwh-018-7-hydroxyindole-metabolite-d9 WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 smoking mixture spices synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 CBs cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic sciences pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 29.253143271526
13824 JWH 018-d9 (solution) - ≥99% deuterated product 2010-06-21 54.097431772776 jwh-018-d9-solution cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cbs synthetic JWH018-d9 JWH-018-d9 JWH-18-d9 JWH 18-d9 JWH18-d9 JWH18d9 10901 54.097431772776
10690 JWH 018 N-(2-methylbutyl) isomer Exclusive - ≥97% 2011-03-16 21.750250279686 jwh-018-n-2-methylbutyl-isomer JWH 073 2-methylbutyl homolog cannabinoids CBs receptors WIN 55,212-2 CB1 cannabimimetics analogs forensics standards JWH-073 JWH 73 JWH73 JWH-73 21.750250279686
10691 JWH 018 N-(3-methylbutyl) isomer Exclusive - ≥97% 2011-02-07 25.015270666904 jwh-018-n-3-methylbutyl-isomer JWH 073 3-methylbutyl homolog cannabinoids agonist selective receptors WIN55212-2 WIN552122 WIN 55212-2 WIN 55,212-2 CB1 cannabimimetics analog forensics CBs JWH-073 JWH-73 JWH 73 JWH73 25.015270666904
9000855 JWH 018 N-(5-hydroxypentyl) metabolite Exclusive - ≥98% 2010-09-01 111.610033422934 jwh-018-n-5-hydroxypentyl-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite five 5 CBs M-5 M5 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 111.610033422934
10933 JWH 018 N-(5-hydroxypentyl) metabolite-d5 Exclusive - ≥99% deuterated product 2011-06-22 79.757840793639 jwh-018-n-5-hydroxypentyl-metabolite-d5 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBs M-5 M5 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 bath salts LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums agonists selective M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 79.757840793639
9000856 JWH 018 N-pentanoic acid metabolite Exclusive - ≥95% 2010-09-01 110.132510405829 jwh-018-n-pentanoic-acid-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 110.132510405829
9000867 JWH 018 N-pentanoic acid metabolite-d4 Exclusive - ≥99% deuterated product 2010-09-15 280.977045593935 jwh-018-n-pentanoic-acid-metabolite-d4 JWH-018 JWH018 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 280.977045593935
13169 JWH 018 (solution) 209414-07-3 ≥98% 2009-03-12 68.923268613605 jwh-018-solution cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 10900 68.923268613605
13633 JWH 019 209414-08-4 ≥98% 2010-01-14 50.127632658708 jwh-019 cannabinoids CB1 CB2 receptors THC JWH-019 JWH019 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinol cannabinmimetic indoles cannabinoids cbs synthetic JWH019 JWH-019 JWH19 JWH 19 JWH-19 50.127632658708
10904 JWH 073 208987-48-8 ≥97% 2011-05-06 40.353743785596 jwh-073 cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 40.353743785596
10716 JWH 073 2-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-03-10 19.228790996521 jwh-073-2-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites monohydroxylated forensics JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 glucuroconjugate JWH-073 JWH073 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 19.228790996521
9000861 JWH 073 4-hydroxyindole metabolite - ≥98% 2010-09-01 43.375395282530 jwh-073-4-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic standards CBs JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 43.375395282530
10717 JWH 073 4-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-02-21 19.579435563740 jwh-073-4-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 19.579435563740
9000862 JWH 073 5-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 37.173574988467 jwh-073-5-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 2 JWH-073 JWH073 CBs M-2 agonists smoking mixtures spices cbs synthetic JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 37.173574988467
10718 JWH 073 5-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-03-11 21.566729128299 jwh-073-5-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics Metabolite 2 JWH-073 JWH073 M-2 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 21.566729128299
9000863 JWH 073 6-hydroxyindole metabolite Exclusive - ≥95% 2010-09-01 33.166485782090 jwh-073-6-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 33.166485782090
10719 JWH 073 6-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-03-11 19.228790996521 jwh-073-6-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 19.228790996521
9000864 JWH 073 7-hydroxyindole metabolite Exclusive - 98% 2010-09-01 30.644219555686 jwh-073-7-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 4 JWH-073 CBs JWH073 M-4 mixtures smoking spices synthetic JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 30.644219555686
10720 JWH 073 7-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-07-25 25.409004024282 jwh-073-7-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics CBs deuterateds deuterium mass spectrometry MS LC/MS LC-MS GC-MS GC/MS WIN55212-2 WIN552122 pain neuroscience JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 25.409004024282
9000868 JWH 073-d7 (solution) Exclusive - ≥99% deuterated product 2010-08-10 35.952230308723 jwh-073-d7-solution deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central cbs synthetic JWH073d7 JWH-073-d7 JWH073-d7 JWH73-d7 JWH-73-d7 JWH73-d7 JWH73d7 10905 35.952230308723
10927 (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) 2011-07-25 46.084455221335 -jwh-073-n-3-hydroxybutyl-metabolite-d5 deuterateds deuterium GC-MS GC/MS LC-MS LC/MS mass spectrometry MS JWH073 JWH73 JWH-073 JWH-73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures pain neuroscience 46.084455221335
9000865 JWH 073 N-(4-hydroxybutyl) metabolite Exclusive - ≥98% 2010-09-01 85.111283486231 jwh-073-n-4-hydroxybutyl-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices M-5 synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 85.111283486231
10934 JWH 073 N-(4-hydroxybutyl) metabolite-d5 Exclusive New - ≥99% deuterated product 2011-10-14 66.724011217090 jwh-073-n-4-hydroxybutyl-metabolite-d5 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M deuterated deuterium metabolites cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices 66.724011217090
9000866 JWH 073 N-butanoic acid metabolite Exclusive - ≥98% 2010-09-01 94.707746633261 jwh-073-n-butanoic-acid-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH 073 Metabolite 6 JWH-073 CBs JWH073 M-6 smoking mixtures spices cbs synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 94.707746633261
9000870 JWH 073 N-butanoic acid metabolite-d5 Exclusive - ≥99% deuterated product 2010-09-20 88.435213297809 jwh-073-n-butanoic-acid-metabolite-d5 JWH 073 Metabolite 6-d5 JWH-073 JWH073 cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 deuterateds deuteriums mass spec GC-MS LC-MS GC/MS LC/MS M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 88.435213297809
13170 JWH 073 (solution) 208987-48-8 ≥97% 2009-03-02 44.560786731709 jwh-073-solution cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 44.560786731709
10579 JWH 081 210179-46-7 ≥98% 2010-10-22 76.572986461864 jwh-081 cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids cbs synthetic JWH-081 JWH 81 JWH-81 JWH81 76.572986461864
10511 JWH 081-d9 New - ≥99% deuterated product 2011-09-08 66.443078325278 jwh-081-d9 cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids CBs synthetic JWH-081 JWH 81 JWH-81 JWH81 standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 66.443078325278
10680 JWH 098 Exclusive 316189-74-9 ≥98% 2011-04-20 51.161757491380 jwh-098 JWH-098 JWH98 JWH-98 JWH 98 cannabinoids cannabimimetics CBs CB1 receptors agonists CB2 pain spice forensics synthetic naphthalen-1-yl-(1-pentylindol-3-yl)methanone 1-propyl-2-methyl-3-(1-naphthoyl)indole 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC 1-pentyl-3-(1-naphthoyl)indole naphthalenes JWH 133 JWH133 JWH-133 JWH-018 JWH018 JWH 018 JWH18 JWH015 JWH15 JWH 015 JWH-015 indoles 51.161757491380
10591 JWH 122 619294-47-2 ≥98% 2010-12-15 86.826609729501 jwh-122 JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs 1 2 CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids cbs synthetic 86.826609729501
10512 JWH 122-d9 New - ≥99% deuterated product 2011-09-08 41.408151914141 jwh-122-d9 JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids CBs synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 41.408151914141
10721 JWH 201 Exclusive 864445-47-6 ≥98% 2011-02-24 77.624510665918 jwh-201 cannabinoids CB1 CB2 receptors CBs JWH201 JWH-201 JWH250 JWH-250 JWH 250 77.624510665918
9000736 JWH 203 864445-54-5 ≥98% 2011-02-21 73.687547154631 jwh-203 cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 cannabimimetics forensics pain CBs binding analgesic 73.687547154631
10644 JWH 210 824959-81-1 ≥98% 2011-02-01 119.609337313713 jwh-210 cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 119.609337313713
10510 JWH 210-d9 New - ≥99% deuterated product 2011-09-08 48.455738971633 jwh-210-d9 cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 JWHs standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS pain 48.455738971633
13634 JWH 250 864445-43-2 ≥98% 2010-01-14 76.881878954195 jwh-250 cannabinoids CB1 CB2 receptors THC JWH-250 JWH250 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinols indoles cbs synthetic 76.881878954195
10661 JWH 250-d5 Exclusive - ≥99% deuterated product 2011-02-14 32.813926949452 jwh-250-d5 cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-250-d5 JWH250-d5 32.813926949452
10578 JWH 251 864445-39-6 ≥98% 2010-08-20 53.611618745255 jwh-251 cannabinoids receptors JWHs JWH-251 JWH251 WIN55212-2 WIN 55212-2 CB1 CB2 cannabimimetics urine forensics cannabinoids cbs synthetic 53.611618745255
10722 JWH 302 Exclusive 864445-45-4 ≥95% 2011-03-04 77.296232569548 jwh-302 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH302 JWH-302 indoles central peripheral GTPγS binding 77.296232569548
13636 JWH 398 Exclusive - ≥95% 2010-10-22 73.228542786809 jwh-398 jwh398 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH-398 cbs synthetic 73.228542786809
13158 JZL 184 1101854-58-3 ≥97% 2009-01-26 160.348107734806 jzl-184 2-AG 2AG MAGL inhibitors inhibits inhibition endocannabinoids pains analgesia MGL inhibitor JZL184 JZL-184 cannabinoids 160.348107734806
13668 JZL 195 - ≥98% 2010-02-10 120.234751381215 jzl-195 fatty acid amide hydrolase FAAH monoacylglycerol lipase MAGL endocannabinoids arachidonoyl ethanolamide AEA 2-arachidonoylglycerol 2-AG inibitors inhibition inhibits PF-3845 PF 3845 PF3845 JZL195 JZL-195 JZL184 antinociception pain catalepsy hypomotility CB1 2AG cannabinoids inhibitors cbs sythetic Methylenedioxybenzenes 1,3-Dioxaindans 1,3 Dioxaindans 1,3-Dioxindans 1,3 Dioxindans Benzodioxoles 120.234751381215
9001148 Ketorolac New 74103-06-3 ≥98% 2012-01-12 102.551822259998 ketorolac Sprix®; Acular PF®; RS 37619; Acular LS® analgesic NSAIDs COX inhibition inhibits inhibitors ocular pain inflammation PGE2 non steroidal anti-inflammatory antiinflammatory drugs heteroaryl acetic acids derivatives cyclooxygenase opthalmalic solutions ocular COX-1 COX-2 COX1 COX2 racemic 66635-83-4 102.551822259998
10009280 L-759,633 174627-50-0 >98% 2007-09-13 35.046546961326 l-759-633 L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry cannabinoids cbs synthetic 35.046546961326
10007712 L-902,688 Exclusive 634193-54-7 ≥98% 2010-05-07 44.592225730070 l-902-688 PGE2 bones growth EP4 agonists hyperalgesia vasodialation 44.592225730070
13453 LH 21 611207-11-5 ≥98% 2011-03-22 17.263738489871 lh-21 cannabimimetic CBs cannabinoids CB1 receptors antagonists pain weight gain obesity LH-21 LH21 central 17.263738489871
9000326 Linoleoyl Glycine 2764-03-6 ≥98% 2008-10-29 5.679337016575 linoleoyl-glycine N-Linoleoyl Glycine; LinGly; Glycine Linoleamide arachidonyl glycine fatty acids AEA FAAH inhibits inhibitor inhibition anandamide homologs 5.679337016575
10563 MDA 19 1048973-47-2 ≥95% 2010-09-17 51.340761641673 mda-19 agonists cannabinoids CB2 CB1 pains 1104302-26-2 tactile allodynia paclitaxel spinal nerves ligation MDA-19 MDA19 CBs peripheral central MDAs central cannabinoids cbs synthetic cannabinoids Epidermal Growth Factor Receptor Protein-Tyrosine Kinase Receptors, Epidermal Growth Factor-Urogastrone Receptor Transforming Growth Factor alpha Transforming Growth Factor alpha Receptor Epidermal Growth Factor Receptor Kinase Receptor Epidermal Growth Factor Receptor erbB 1 Proto Oncogene Protein Receptor Urogastrone Urogastrone Receptor Receptor TGF alpha TGF-alpha Receptor c-erbB-1 Protein Proto-Oncogene Receptor EGF EGF Receptor 51.340761641673
10639 MDA 77 Exclusive 1103774-21-5 ≥98% 2011-05-16 4.063591160221 mda-77 CB2 inverse agonists inflammation pain CB1 CBs cannabinoids peripheral MDA77 MDA-77 in vivo binds binding assay 4.063591160221
10007812 Monoacylglycerol Lipase (human recombinant) - >95% 2008-04-01 53.800283149171 monoacylglycerol-lipase-human-recombinant MAGL; MGL neuroscience neurochemistry 2-AG endocannabinoids hydrolases proteins MAGLs MGLs recombinant 53.800283149171
10009566 Monoacylglycerol Lipase Western Ready Control - Whole cell lysate 2007-01-31 9.678011049723 monoacylglycerol-lipase-western-ready-control MGL; MAGL hormone-sensitive lipases HSL kidney spleen heart liver testis stomach brain lung adrenal gland keletal muscle adipose tissue neurochemistry 9.678011049723
10004184 NESS 0327 Exclusive 494844-07-4 >98% 2008-05-27 38.872345554997 ness-0327 neurochemistry neuroscience cannabinoids antagonist CB1 CB2 SR 141716A rimonabant WIN 55212-5 pain obesity 38.872345554997
10007697 N-Palmitoyl Dopamine 136181-87-8 >98% 2005-11-23 5.533591160221 n-palmitoyl-dopamine PALDA N-acyls fatty anologs N-araachidonoyl NADA N-oleoyl ODA bovine brains amides palmitic acids hybrids anandamides neurotransmitter pathways inactive vanilloid receptors 1 VR1 ligands hyperalgesics nocifensives responses in vivo entourage effects neurochemistry cannabinoids cbs synthetic 5.533591160221
10009020 N-Palmitoyl Glycine 2441-41-0 ≥98% 2009-12-01 9.929088397789 n-palmitoyl-glycine N-Hexadecanoyl-Glycine; PalGly pain inflammation AEA anandamides DRG nociception calcium influx arachidonoyl amides glycines 9.929088397789
10009195 O-2545 (hydrochloride) - >98% 2007-07-12 1.533701657459 o-2545-hydrochloride cannabinoids water soluble agonists receptors CB1 CB2 lipophilic surfactants 874745-42-3 murine models intravenously IV 02545 intracerebroventricularly endocrinology neurochemistry cannabinoids cbs synthetic 1.533701657459
10010547 O-Arachidonoyl Glycidol Exclusive 439146-24-4 >98% 2008-03-31 18.812883977900 o-arachidonoyl-glycidol 2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL cannabinoids 18.812883977900
9000629 Oleoyl Serotonin Exclusive 1002100-44-8 ≥98% 2010-05-18 5.339305445935 oleoyl-serotonin N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA Hydrolase Long-Chain Fatty-Acyl-CoA Fatty-Acyl-CoA Hydrolase Long-Chain Long-Chain Fatty-Acyl-CoA Hydrolase Long Chain Fatty Acyl CoA Hydrolase Palmitoyl Coenzyme A Hydrolase Acylhydrolase Oleoyl-CoA Thioesterase Fatty Acyl Oleoyl-CoA Acylhydrolase Oleoyl CoA Acylhydrolase Hydrolase Palmitoyl-CoA Deacylase, Palmitoyl CoA CoA Deacylase, Palmitoyl Thioesterase, Palmitoyl Palmitoyl-CoA Hydrolase Palmitoyl CoA Hydrolase Palmitoyl CoA Deacylase Hydrolase Stearoyl CoA Fatty Acyl Thioesterase CoA Hydrolase Stearoyl Stearoyl CoA Hydrolase Palmitoyl Thioesterase Hydrolase Acyl CoA CoA Hydrolase Acyl Acyl CoA Hydrolase Thioesterase I 5.339305445935
9000694 Oleoyl Serotonin-d17 Exclusive - ≥99% deuterated product 2010-09-27 5.120520915548 oleoyl-serotonin-d17 N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA deuterateds deuteriums MS mass spectrometry GC-MS LC-MS GC/MS LC/MS standards 5.120520915548
14070 ONO-8711 216158-34-8 ≥98% 2011-06-15 21.005331491712 ono-8711 ONO 8711 ONO8711 prostaglandins EPs EP1 receptors potent PGs antagonists AH-6809 AH 6809 AH6809 14060 14050 SC-19220 SC19220 SC 19220 21.005331491712
9000630 Palmitoyl Serotonin Exclusive 212707-51-2 ≥98% 2010-05-18 5.471902131018 palmitoyl-serotonin N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA Hydrolase Long-Chain Fatty-Acyl-CoA Fatty-Acyl-CoA Hydrolase Long-Chain Long-Chain Fatty-Acyl-CoA Hydrolase Long Chain Fatty Acyl CoA Hydrolase Palmitoyl Coenzyme A Hydrolase Acylhydrolase Oleoyl-CoA Thioesterase Fatty Acyl Oleoyl-CoA Acylhydrolase Oleoyl CoA Acylhydrolase Hydrolase Palmitoyl-CoA Deacylase Palmitoyl CoA CoA Deacylase Palmitoyl Thioesterase Palmitoyl Palmitoyl-CoA Hydrolase Palmitoyl CoA Hydrolase Palmitoyl CoA Deacylase Hydrolase Stearoyl CoA Fatty Acyl Thioesterase CoA Hydrolase Stearoyl Stearoyl CoA Hydrolase Palmitoyl Thioesterase Hydrolase Acyl CoA CoA Hydrolase Acyl Acyl CoA Hydrolase Thioesterase I 5.471902131018
13279 PF-3845 1196109-52-0 ≥98% 2010-01-27 37.992885205648 pf-3845 fatty acids hydrolase FAAH N-acyl ethanolamines NAEs endocannabinoids N-arachidonoyl ethanolamine anandamide AEA inhibitors inhibits inflammation pain PF3845 PF 3845 cannabinoids cbs synthetic Antibodies Monoclonal Monoclonal Antibodies 37.992885205648
10010907 PF-622 898235-65-9 >98% 2008-03-26 6.383455163621 pf-622 FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain fatty acids amides hydrolases neurochemistry 6.383455163621
10010908 PF-750 959151-50-9 >98% 2008-03-25 11.288732734806 pf-750 FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain neurochemistry 11.288732734806
13368 Piroxicam 36322-90-4 ≥95% 2010-01-06 17.139206349206 piroxicam NSC 666076; Larapam; Feldene inflammation NSAIDs inhibitors cyclooxygenases COX-1 COX-2 analgesic pain arthritis cancers Artrooxicam Baxo Bruxicam CP 16171 Geldene Neoxicam Reudene Roxicam Roxiden Sasulen Solocalm Uphaxicam Zunden inhibition inhibited inflammatory Piroxicam CP-16171 CP 16171 Feldene CP16171 17.139206349206
10006973 Pravadoline 92623-83-1 ≥98% 2011-02-08 49.107296654389 pravadoline WIN 48,098 Anti-inflammatory analgesic COX inhibitors pain AAI NSAIDs inhibits inhibition prostaglandins PGs synthesis murine inhibited mouse cyclooxygnases opoid Indoles receptors WIN48098 WIN-48098 WIN 48098 WIN-48,8098 49.107296654389
13621 Pristimerin Exclusive 1258-84-0 ≥98% 2010-03-08 42.875840568271 pristimerin Celastrol methyl ester; NSC 99281 monoacylglycerol lipases MAGLs monoglycerol MGLs cannabinoids 2-arachidonoyl glycerol 2-AG inhibitor 2-Picenecarboxylic acids cannabinoids cbs synthetic Triterpenes 42.875840568271
10007684 Prostaglandin D Synthase (lipocalin-type; human) EIA Kit Exclusive - 2008-06-09 18.893540515653 prostaglandin-d-synthase-lipocalin-type-human-eia-kit Lipocalin-PGDS ELISA Kit; L-PGDS EIA Kit EIAs ELISAs Assays sandwich immunometric homodimer glycosylation catalyzes prostaglandins PGH2 PGD2 carrier proteins lipid-like molecules neurochemistry retinoids thyroid hormones body fluids cerebrospinal seminal plasma PTGDS beta-trace b-trace .beta.-trace betatrace btrace lpgds l-pgds assays 18.893540515653
10384 Prostaglandin E2 isopropyl ester Exclusive 71845-66-4 ≥98% 2010-06-07 324.828397790054 prostaglandin-e2-isopropyl-ester PGE2 inflammation fertility parturition immunology reproductive biology pain prostaglandins E2 lipophilic 324.828397790054
10007939 Prostaglandin E Synthase-1 (microsomal) (human recombinant) - 16,000 x g supernatant 2009-03-15 25.421565377532 prostaglandin-e-synthase-1-microsomal-human-recombinant Membrane-Associated PGES-1; Prostaglandin H/E Isomerase; PIG12; mPGE Synthase-1; MGST1-L1 enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 25.421565377532
10009734 Prostaglandin E Synthase-1 (microsomal) Western Ready Control - 2007-05-01 8.713128453038 prostaglandin-e-synthase-1-microsomal-western-ready-control PIG12; mPGE Synthase-1; MGST-L1; Prostaglandin H/E Isomerase; Memebrane-Associated PGES-1 western blot WB prostaglandins renal failure synthase inhibitors mPGES mPGES-1 mPGES1 8.713128453038
10011032 QX-314 (bromide) 24003-58-5 ≥98% 2009-02-03 0.216574585635 qx-314-bromide lidocaine local anesthetic TRPV1 sodium channel blocker pain nociceptor capsaicin 0.216574585635
10491 (R)-AM1241 Exclusive 444912-51-0 ≥98% 2010-05-27 39.482488234090 -r-am1241 (+)-AM1241 cannabinoids CB2 receptors CB1 agonists inverse agonists antinociception pains SR144528 rimonabant CBs 39.482488234090
10645 RCS-4 - ≥98% 2010-11-24 127.480315197521 rcs-4 cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics CBs neurochemistry cannabinoids cbs synthetic 127.480315197521
10513 RCS-4-d9 New - ≥99% deuterated product 2011-09-12 44.447019892911 rcs-4-d9 cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics sciences CBs neurochemistry synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 44.447019892911
10636 RCS-8 Exclusive - ≥98% 2010-11-02 110.680693566903 rcs-8 SR-18 cannabinoids receptors JWH 250 CB1 CB2 cannabimimetics forensics cannabinoids cbs synthetic Rabbit Aorta Contracting Substance A2 Thromboxane Thromboxane A2 110.680693566903
10490 (S)-AM1241 Exclusive 444912-53-2 ≥98% 2010-05-27 44.391381093392 -s-am1241 (-)-AM1241 cannabinoids CB2 receptors CB1 agonists inverse agonist antinociception pains SR144528 rimonabant CBs 44.391381093392
11019 SB 366791 New 472981-92-3 ≥98% 2011-10-13 5.295556823889 sb-366791 pain TRPV1 antagonists hyperalgesia receptors neurons central peripheral nerves terminals thermal mechanical hyperalgesia bone cancers ganglion SB366791 SB-366791 5.295556823889
10011561 SC-51089 146033-02-5 ≥95% 2010-02-02 7.626353591159 sc-51089 CID132748 prostaglandins E2 PGE2 receptors EP1 pain antagonists analgesia glioma cells cancers tumors growth neuroprotection neurons oxidative stress SC51089 SC 51089 PGs Oxazepines 7.626353591159
10010744 SC-51322 146032-79-3 >98% 2010-03-09 14.510596685082 sc-51322 SC51322 SC 51322 prostaglandins E2 PGE2 receptors EP1 pain vasorelaxation inflammation PGs inflammatory signaling signalling antagonist Misoprostol, (11alpha,13Z)-(+-)-Isomer Misoprostol, (11beta,13E)-(+-)-Isomer Misoprostol (11alpha.13E,16S)-Isomer Misoprostol (11alpha,13E,16R)-Isomer Misoprostol, (11beta,13E,16S)-Isomer Misoprostol, (11beta,13E,16R)-Isomer Misoprostol (11alpha,13E)-Isomer Grunenthal Brand of Misoprostol Novopharm Brand of Misoprostol Misoprostol Grunenthal Brand Pfizer Brand of Misoprostol Misoprostol Novopharm Brand Apotex Brand of Misoprostol Misoprostol Pfizer Brand Misoprostol Apotex Brand Novo-Misoprostol Novo Misoprostol Apo-Misoprostol Apo Misoprostol Misoprostol SC-30249 SC-29333 SC 30249 SC 29333 SC30249 SC29333 Cytotec Glefos 14.510596685082
10012555 Sodium Hydrogen Sulfide (hydrate) 207683-19-0 ≥65% 2009-09-03 26.704851647227 sodium-hydrogen-sulfide-hydrate Sodium Hydrosulfide; NSC 158264; NaHS hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 26.704851647227
9000491 SR 144528 192703-06-3 ≥98% 2009-08-05 71.692483118478 sr-144528 antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs synthetic 71.692483118478
9000631 Stearoyl Serotonin Exclusive 67964-87-8 ≥98% 2010-05-18 5.296211523283 stearoyl-serotonin N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA Hydrolase Desaturase Stearoyl-CoA Stearoyl-CoA Desaturase Stearoyl CoA Desaturase Desaturase Stearyl-CoA Stearyl-CoA Desaturase Stearyl CoA Desaturase Desaturase Stearate Stearate Desaturase Desaturase delta-9 delta-9 Desaturase 5.296211523283
13830 Synthetic Cannabinoid HPLC Mixture I - ≥95% for each compound 2010-05-13 39.243082614455 synthetic-cannabinoid-hplc-mixture-i cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes synthetic 39.243082614455
13850 Synthetic Cannabinoid HPLC Mixture II - ≥95% for each compound 2010-12-21 39.551017802333 synthetic-cannabinoid-hplc-mixture-ii cannabinoids CBs synthetics mixtures receptors agonists synthetic 39.551017802333
11337 Synthetic Cannabinoid HPLC Mixture V (AM Series) New - ≥95% for each compound 2012-02-02 101.640890116636 synthetic-cannabinoid-hplc-mixture-v-am-series AM series AM-2201 AM-1220 AM-630 AM-1241 AM-694 AM-2233 AM2201 AM1220 AM630 AM1241 AM694 CBs cannbinoids mixtures AM2233 101.640890116636
10674 URB937 Exclusive - ≥98% 2011-03-08 17.586224677716 urb937 FAAH anandamide AEA inhibitors peripheral pain Cannabinoids 17.586224677716
10736 (±)WIN 55212 (mesylate) New 137795-17-6 ≥98% 2012-01-11 110.382203395478 -win-55212-mesylate cannabinoids CB1 CB2 receptors pain neuroscience agonists antagonists aminoalkylindole CBs enantiomers (+)WIN 55212-2 (-)WIN 55215-3 SR144528 SR-144528 SR 144528 racemic mesylate central peripheral 110.382203395478
13665 YS121 Exclusive 916482-17-2 ≥98% 2010-04-02 20.004903314917 ys121 Microsomal Prostaglandin E2 Synthase-1 mPGES-1 cyclooxygenase-2 COX-2 PGE2 inflammation fever pain 5-Lipoxygenase 5-LO leukotrienes LTs inhibitors LTB4 cyclooxygenase-1 COX-1 LTC4 LTD4 LTE4 inhibition Pyrimidines inhibits PGs YS 121 YS-121 20.004903314917
13271 ZLJ-6 Exclusive 1051931-39-5 ≥98% 2009-06-17 38.591892265193 zlj-6 inhibitors cyclooxygenase COX-1 COX-2 5-lipoxygenase 5-LO inflammation pain ZLJ6 ZLJ 6 38.591892265193
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?